We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...

At the Pondy Lit Fest 2024, an insightful discussion took place on the future of mRNA technology in malaria vaccine ...

A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

THE LAWSUIT: A class action securities lawsuit was filed against Moderna, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 18, ...

NPR's coverage of their effort to invent an mRNA vaccine that would be free for all countries to manufacture brought them an ...

Based on the high rate of global immunity and currently available data, the State Surgeon General advises against the use..." ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...

Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar ...

由此可见，mRNA-4157（V940）联合帕博利珠单抗在黑色素瘤患者中耐受性良好。 而mRNA-4157（V940）预计最早在2025年上市，这将会是全球首款mRNA肿瘤疫苗。

In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on Moderna (MRNA – Research Report), with a price ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...